Filing Details
- Accession Number:
- 0001725160-23-000200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-13 17:24:08
- Reporting Period:
- 2023-11-13
- Accepted Time:
- 2023-11-13 17:24:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1725160 | Zentalis Pharmaceuticals Inc. | ZNTL | Pharmaceutical Preparations (2834) | 823607803 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816465 | Kimberly Blackwell | C/O Zentalis Pharmaceuticals, Inc. 1359 Broadway, Suite 801 New York NY 10018 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-13 | 5,000 | $10.29 | 254,800 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
